Aaron Schwimmer joined MTS Health Partners in 2024 as a Partner.  Aaron has spent over 20 years in various roles within the biotech sector and will leverage that experience to help drive the firm’s growth.

Aaron joined MTS after 15 years in the investment banking groups at Bank of America and Barclays where he covered the biotech and broader life sciences sector. Over the course of his investment banking career, Aaron has advised on a range of transactions including private, public and PIPE financings, partnerships and M&A

Prior to investment banking Aaron was part of the Business Development team at MedImmune and a biotech equity research analyst at Goldman Sachs.